Below are the most recent publications written about "Mice, Inbred BALB C" by people in Profiles.
-
Du K, Zhang X, Qin Y, Ma H, Bing C, Deng S, Chen Y, Qin J, Chang S, Xiao S, Peng L, Xie X, Feng X, Fu X, Wei Y, Fan X, Ashktorab H, Smoot D, Jin Z, Peng Y. MAP3K13-232aa encoded by circMAP3K13 enhances cisplatin-induced pyroptosis by directly binding to IKKa in gastric adenocarcinoma. Cell Death Dis. 2025 Sep 01; 16(1):667.
-
Chang S, Fu X, Xiang L, Yuan Y, Xiao S, Peng L, Xie X, Kang X, Feng X, Ashktorab H, Peng Y, Jin Z, Zhang X. A novel protein encoded by circTUBGCP3 blocks ferroptosis and promotes gastric cancer progression. J Biol Chem. 2025 09; 301(9):110507.
-
Iniguez E, Rodriguez F, Husseneder C, Foil L, Maldonado RA. Ligand-lytic peptides for specific targeting of Leishmania major and Trypanosoma cruzi parasites. Front Cell Infect Microbiol. 2025; 15:1595333.
-
Ruidas B, Choudhury N, Chaudhury SS, Sur TK, Bhowmick S, Saha A, Das P, De P, Das Mukhopadhyay C. Precision targeting of fat metabolism in triple negative breast cancer with a biotinylated copolymer. J Mater Chem B. 2025 01 22; 13(4):1363-1371.
-
Eom S, Park SG, Koo Y, Noh Y, Choi C, Kim Y, Jun H, Cha C, Joo J, Kang S. In situ forming and self-crosslinkable protein hydrogels for localized cancer therapy and topical wound healing. J Control Release. 2025 Feb 10; 378:460-475.
-
Cruz-Collazo AM, Katsara O, Grafals-Ruiz N, Colon Gonzalez J, Dorta-Estremera S, Carlo VP, Chorna N, Schneider RJ, Dharmawardhane S. Novel Inhibition of Central Carbon Metabolism Pathways by Rac and CDC42 inhibitor MBQ167 and Paclitaxel. Mol Cancer Ther. 2024 Nov 04; 23(11):1613-1625.
-
Nathani A, Khan I, Tanimoto MH, Mej?a JAA, DE Miranda AM, Rishi A, Dev S, Bastos JK, Singh M. Antitumor Potential of Guttiferone E Combined With Carboplatin Against Osimertinib-resistant H1975 Lung Cancer Through Apoptosis. Anticancer Res. 2024 Oct; 44(10):4175-4188.
-
Wang J, Hou Q, Qu J, Huo X, Li H, Feng Y, Wang Q, Chang L, Xu C. Polyhedral magnetic nanoparticles induce apoptosis in gastric cancer stem cells and suppressing tumor growth through magnetic force generation. J Control Release. 2024 Sep; 373:370-384.
-
Adekiya TA, Hudson T, Bakare O, Ameyaw EE, Adebayo A, Olajubutu O, Adesina SK. PSMA-targeted combination brusatol and docetaxel nanotherapeutics for the treatment of prostate cancer. Biomed Pharmacother. 2024 Aug; 177:117125.
-
Jesus MM, Lage DP, Vale DL, Freitas CS, Pimenta BL, Moreira GJL, Ramos FF, Pereira IAG, Bandeira RS, Ludolf F, Tavares GSV, Galdino AS, Duarte MC, Menezes-Souza D, Ch?vez-Fumagalli MA, Teixeira AL, Gon?alves DU, Roatt BM, Christodoulides M, Martins VT, Coelho EAF. Immunization with recombinant LiHyp1 protein plus adjuvant is protective against tegumentary leishmaniasis. Parasitol Res. 2023 Dec; 122(12):2917-2931.